Análisis de la acción Waters Corp (WAT)WATWaters Corp

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Waters Corp is a good buy right now due to its recent strong earnings report showing Q2 2026 revenue of $1.645 billion, a 7% year-over-year increase, and an upgraded analyst price target of $480, which suggests significant upside from the current price of $414.69. However, a risk to consider is the recent negative net income reported for Q1 and Q2 of 2026, which was -72 million and -136 million USD, respectively.

15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.